BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 25645722)

  • 1. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.
    Villanueva A; Portela A; Sayols S; Battiston C; Hoshida Y; Méndez-González J; Imbeaud S; Letouzé E; Hernandez-Gea V; Cornella H; Pinyol R; Solé M; Fuster J; Zucman-Rossi J; Mazzaferro V; Esteller M; Llovet JM;
    Hepatology; 2015 Jun; 61(6):1945-56. PubMed ID: 25645722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
    J Pathol; 2014 Aug; 233(4):392-401. PubMed ID: 24838394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.
    Arai E; Ushijima S; Gotoh M; Ojima H; Kosuge T; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
    Int J Cancer; 2009 Dec; 125(12):2854-62. PubMed ID: 19569176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
    Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
    J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.
    Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H
    Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.
    Bedon L; Dal Bo M; Mossenta M; Busato D; Toffoli G; Polano M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
    Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
    Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
    Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.
    Hernandez-Vargas H; Lambert MP; Le Calvez-Kelm F; Gouysse G; McKay-Chopin S; Tavtigian SV; Scoazec JY; Herceg Z
    PLoS One; 2010 Mar; 5(3):e9749. PubMed ID: 20305825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
    Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK
    Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methylation Profiling of Human Hepatocarcinogenesis.
    Hernandez-Meza G; von Felden J; Gonzalez-Kozlova EE; Garcia-Lezana T; Peix J; Portela A; Craig AJ; Sayols S; Schwartz M; Losic B; Mazzaferro V; Esteller M; Llovet JM; Villanueva A
    Hepatology; 2021 Jul; 74(1):183-199. PubMed ID: 33237575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma.
    Deng YB; Nagae G; Midorikawa Y; Yagi K; Tsutsumi S; Yamamoto S; Hasegawa K; Kokudo N; Aburatani H; Kaneda A
    Cancer Sci; 2010 Jun; 101(6):1501-10. PubMed ID: 20345479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.